Jackson, Grant Investment Advisers, Inc. Teva Pharmaceutical Industries LTD Transaction History
Jackson, Grant Investment Advisers, Inc.
- $265 Million
- Q3 2024
A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 122 shares of TEVA stock, worth $2,777. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122
Previous 122
-0.0%
Holding current value
$2,777
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
625Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$979 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$825 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$787 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$657 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$603 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $25.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...